Previous 10 |
home / stock / redif / redif news
RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of Opaganib for COVID-19 RedHill adds two more manufacturing partners, both U.S.-based, for large-scale manufacturing of opaganib, in preparation for potential emergency use applications as early as Q1/2021 The new ...
RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease RHB-204 is being evaluated as a first-line, stand-alone, oral treatment for pulmonary nontuberculous mycobacteria (NTM) disease - a rare condition with no FDA-approved first-line therapy...
RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib - Data Expected in the Coming Weeks Enrollment completed in the U.S. Phase 2 study evaluating opaganib's safety and initial efficacy signal in 40 hospitalized patients with severe COVID-19 pneum...
RedHill Biopharma Ltd. (RDHL) Q3 2020 Earnings Conference Call November 12, 2020 08:30 AM ET Company Participants Alexandra Okmian - Senior Business Development and Investor Relations Manager Dror Ben-Asher - Chief Executive Officer Micha Chorin - Chief Financial Officer Rick Scruggs - Chief ...
The following slide deck was published by RedHill Biopharma Ltd. in conjunction with their 2020 Q3 earnings call. For further details see: RedHill Biopharma Ltd. 2020 Q3 - Results - Earnings Call Presentation
RedHill Biopharma Ltd (RDHL) Q2 2020 Earnings Conference Call August 13. 2020 08:30 AM ET Company Participants Shani Maurice - Vice President, Business Development and Communications Dror Ben-Asher - Chief Executive Officer Micha Ben Chorin - Chief Financial Officer Guy Goldber...
AstraZeneca reports positive data for nirsevimab AstraZeneca (AZN) announced positive data for nirsevimab for the passive immunization against respiratory syncytial virus ((RSV)) infections in healthy preterm infants. The data showed that the treatment was able to provide favorable resul...
Redhill Biopharma Ltd (RDHL) Q1 2020 Earnings Conference Call May 27, 2020, 08:30 ET Company Participants Dror Ben-Asher - Co-Founder, Chairman & CEO Micha Ben-Chorin - CFO Gilead Raday - COO Rick Scruggs - Chief Commercial Officer, Head, USA Operations & Director Co...
The following slide deck was published by RedHill Biopharma Ltd. in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd Ord Company Name:
REDIF Stock Symbol:
OTCMKTS Market:
Redhill Biopharma Ltd Ord Website:
RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results Canada NewsWire RedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against Omicron Acting independently of spike protein mutation...
RedHill Biopharma Announces Closing of $15.5 Million Public Offering of American Depositary Shares PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , Nov. 23, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty b...
RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients Canada NewsWire - Recruitment completed for Part A of the Phase 2/3 study of once-daily orally-administered RHB-107...